fecal calprotectin is released in colon by activated neutrophils. investigation of diagnostic application of determination of fecal calprotectin levels is considered by many researchers to compare between different colorectal diseases like irritable bowel syndrome (ibs) and inflammatory bowel diseases (ibd). due to the effect of nutrition habits on the inflammatory processes of bowel, the main ...

BACKGROUND There is increasing evidence that intestinal inflammation plays a major role in gastrointestinal symptoms in cystic fibrosis (CF). Fecal calprotectin is a marker that is elevated in several gastrointestinal inflammatory diseases, but little is known about its value in CF. We aimed to look for associations of elevated fecal calprotectin among CF patients and whether its level correlat...

Background Inflammatory bowel disease (IBD) is a chronic disease with a relapsing course of inflammation in the digestive system. Endoscopy and histopathology are the golden standard methods for detection and assessment of IBD. A distinct increase of fecal calprotectin level can be a useful marker for the diagnosis of IBD. The aim of this study was to evaluate the fecal calprotectin level in pa...

BACKGROUND Fecal calprotectin has been proposed as a non-invasive marker of intestinal inflammation in inflammatory bowel disease in adults and children. Fecal calprotectin levels have been reported to be much higher in both healthy full-term and preterm infants than in children and adults. OBJECTIVE To determine the time course of fecal calprotectin (f-calprotectin) excretion in preterm infa...

BACKGROUND Roux-en-Y gastric bypass (RYGB) causes several alterations in gastrointestinal function. We hypothesized that levels of three commonly used fecal tests change after RYGB. METHODS Fecal levels of calprotectin, elastase, and alpha-1-antitrypsin were determined in 122 patients without signs of gastrointestinal disease 1 to 2 years after RYGB. Medians, distribution of values, and the p...

The Crohn’s disease (CD) activity index (CDAI) has formed the basis for all the major clinic trials in CD over the years since its publication in 1976 [1]. It is, however, beset with problems namely the requirement for a patient symptom diary, the fact that subjective criteria account for 40% of the score and, moreover, the fact that it does not correlate with the inflammatory burden in CD. Thu...

62 Use of Lactobacillus GG for Treatment of Allergic Colitis in Children Cow’s milk protein allergy (CMPA) is a relatively common gastrointestinal disease in infants and is associated with rectal bleeding and diarrhea. CMPA involves intestinal inflammation, and fecal calprotectin, a marker of intestinal inflammation, may be helpful in following the disease course of CMPA. The authors of this st...

we conducted this study to compare fecal calprotectin between exclusively breastfed and formula or mixed fed infants aged one month and six months. sixty term infants were enrolled from the labor ward of valiasr hospital between oct 2011 and july 2015 and their fecal calprotectin was checked by the elisa method and hycult biotech kits. the enrolled infants had a birth weight of 2500-4000 g and ...

In 54/64 subjects with nosocomial diarrhea, fecal calprotectin levels correlated with the results of stool samples tested for Clostridium difficile toxin gene by PCR. Fecal calprotectin levels can be used as an adjunctive measure to PCR to support the diagnosis of C. difficile infection.

BACKGROUND Crohn's disease (CD) activity index (CDAI) is still widely used for monitoring clinical activity in CD patients, but is of little value as indicator of persistent inflammation in symptomless patients. Fecal calprotectin levels ≥150 µg/g are strongly indicative of endoscopically and/or histologically active disease. Our aim was to study, in a large cohort of CD patients, the relations...